The global low GI rice market size was valued at USD 3.12 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2020 to 2027. The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular diseases, among the working-class and old age populations, is boosting the market growth. Moreover, health-conscious customers are increasingly adopting low glycemic index foods, such as rice, flattened rice, and other food products. These consumer trends are expected to open new opportunities for the market over the forecast period. The Glycemic Index (GI) of rice or any food is a relative ranking based on the rise of glucose level in the blood within two hours after consuming food. This glycemic index is an assigned number to food from 0 to 100 and foods having a GI value below 55 are considered to be low GI foods. These foods or rice are slowly metabolized, digested, and absorbed, which leads to a slower rise in blood sugar.
These properties are beneficial for diabetic patients, and hence the demand for the product is likely to witness significant growth in the years to come. Over the past few years, the prevalence of chronic diseases has increased significantly across the globe owing to little or no physical activity, dependence on junk food, fluctuating diet plans, and irregularity in meals. In addition, sitting jobs and hectic work culture have propelled the number of diseases among people worldwide. Such lifestyles of the consumers lead to various diseases, such as diabetes, cardiovascular diseases, blood pressure, and other related diseases. These consumer trends are propelling the demand for low GI rice across the globe.
Diabetes is one of the fastest-growing diseases among the working-class population and the young generation. According to the statistics provided by the World Health Organization (WHO), in 2019, more than 422 million people across the globe have diabetes and it is one of the leading causes of deaths throughout the world. Such rising health-related issues are propelling the demand for low GI rice across the globe.
From the starting of 2020, due to the sudden breakdown of a novel COVID-19, the majority of countries around the world have imposed strict lockdown at the country levels to contain this deadly virus in their countries. As a result, staple food supplies to supermarkets and hypermarkets have negatively impacted all the major countries. However, gradually, with the number of vaccines coming, the world market has removed restrictions on global supplies across the globe, thus opening new opportunities worldwide.
The online retail segment was the largest distribution channel with a share of exceeding 55.0% in 2019. The low GI food products, especially rice, have limited product visibility. The market is in a nascent stage, and hence manufacturers in the market target customers through social media, e-commerce websites, and other digital advertisement agencies. In addition, these e-commerce websites offer a wide range of products by many manufacturers worldwide. Therefore, if the product is not available in the country, customers can order it from any other region through these e-commerce websites.
The hypermarket and supermarket distribution channel segment is anticipated to be the fastest-growing segment with a CAGR of 5.3% from 2020 to 2027. With the increasing demand for diabetic food, customers across the globe are increasingly adopting low GI food products, especially rice. In the past few years, the prevalence of diabetes has been increasing in some major economies and highly populated nations, such as India and China. Manufacturers are now making a large variety of low GI rice products available that can suit many population groups worldwide. These market trends are propelling the demand for this product.
Asia Pacific was the largest regional market for low GI rice, accounting for exceeding 50.0% share in 2019. China and India are the two largest populated nations in the world, are also the largest producers of rice in the world. These countries being the two most populated nations in the world, the prevalence of diabetes is also very high, which generated the demand for low GI rice in the region. Australia is one of the largest markets for low GI rice as the awareness of these products is high among consumers.
Europe is anticipated to be the fastest-growing regional market with a CAGR of 5.5% from 2020 to 2027 due to the increasing demand for diabetic food. According to the World Health Organization (WHO), 60 million people are suffering from diabetes in the region. These health concerns are propelling the demand for low GI rice in the region.
The market is in its nascent stage and is exceptionally fragmented. Moreover, the demand for the product has witnessed a rise in the recent years owing to its premiumization. Manufacturers adopt various strategies, including product promotions, product launches, collaborations, and expansion of distribution channels, in order to capture a significant share in the market and expand their customer base across the globe. For instance, in September 2016, SunRice, a renowned brand of Ricegrowers Limited, collaborated with GI Foundation and relaunched its wide range of products. These marketing strategies propelled the demand among consumers, which anticipated to boost the market growth in the near future. Some prominent companies in the global low GI rice market include:
Ricegrowers Limited
Nestiva Green LLP
Chaman Lal Setia Exports Ltd.
SDLG Radiant Private Limited
Sugar Watchers
First Choice Foods Pvt. Ltd.
Report Attribute |
Details |
Market size value in 2020 |
USD 3.27 billion |
Revenue forecast in 2027 |
USD 4.60 billion |
Growth Rate |
CAGR of 4.9% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; MEA |
Country scope |
U.S.; U.K.; Germany; France; Australia; India; Brazil |
Key companies profiled |
Ricegrowers Limited; Nestiva Green LLP; Chaman Lal Setia Exports Ltd.; SDLG Radiant Private Limited; Sugar Watchers; First Choice Foods Pvt. Ltd. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global low GI rice market report on the basis of distribution channel and region:
Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)
Hypermarket & Supermarket
Online Retail
Others
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Europe
The U.K.
Germany
France
Asia Pacific
Australia
India
Central & South America
Brazil
Middle East & Africa
b. The global low GI rice market size was estimated at USD 3.12 billion in 2019 and is expected to reach USD 3.27 billion in 2020.
b. The global low GI rice market is expected to grow at a compound annual growth rate of 4.9% from 2020 to 2027 to reach USD 4.60 billion by 2027.
b. Asia Pacific was the largest market for low GI rice accounting for a market share of more than 50.0% in 2019. The prevalence of diabetes is also very high which generated the demand for the low GI rice in the region.
b. Some key players operating in the low GI rice market include Ricegrowers Limited, Nestiva Green LLP, Chaman Lal Setia Exports Ltd., SDLG Radiant Private Limited, Sugar Watchers, First Choice Foods Pvt. Ltd.
b. Key factors that are driving the low GI rice market growth include the increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases among the working-class and old age population and new product launches.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."